P. C. Vincent

1.1k total citations
59 papers, 817 citations indexed

About

P. C. Vincent is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, P. C. Vincent has authored 59 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Hematology and 13 papers in Genetics. Recurrent topics in P. C. Vincent's work include Blood disorders and treatments (13 papers), Neutropenia and Cancer Infections (11 papers) and Hematological disorders and diagnostics (7 papers). P. C. Vincent is often cited by papers focused on Blood disorders and treatments (13 papers), Neutropenia and Cancer Infections (11 papers) and Hematological disorders and diagnostics (7 papers). P. C. Vincent collaborates with scholars based in Australia, United Kingdom and Ireland. P. C. Vincent's co-authors include F. W. Gunz, John A. Levi, G. A. R. Young, G. C. de Gruchy, Paul Forrest, John H. Gallo, P.E. Crossen, Lewis M. Schiffer, Sally M. Pittman and Michael Greenberg and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

P. C. Vincent

57 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. C. Vincent Australia 15 228 167 163 139 136 59 817
K. C. Carstairs Canada 14 272 1.2× 95 0.6× 148 0.9× 148 1.1× 121 0.9× 28 875
Richard L. DeGowin United States 19 338 1.5× 176 1.1× 185 1.1× 243 1.7× 70 0.5× 45 1.0k
I. W. Delamore United Kingdom 22 308 1.4× 152 0.9× 75 0.5× 132 0.9× 132 1.0× 68 1.2k
Stanley L. Lee United States 24 290 1.3× 180 1.1× 101 0.6× 162 1.2× 191 1.4× 36 1.7k
M Schattenkirchner Germany 22 316 1.4× 193 1.2× 95 0.6× 153 1.1× 71 0.5× 82 1.6k
Mammo Amare United States 14 362 1.6× 216 1.3× 110 0.7× 81 0.6× 38 0.3× 28 827
Frank Firkin Australia 19 418 1.8× 318 1.9× 108 0.7× 206 1.5× 128 0.9× 67 1.3k
K Grünewald Austria 15 224 1.0× 175 1.0× 79 0.5× 114 0.8× 65 0.5× 30 846
D.G. Chalmers United Kingdom 16 176 0.8× 93 0.6× 106 0.7× 96 0.7× 68 0.5× 36 911
R. Dean Wochner United States 15 153 0.7× 87 0.5× 110 0.7× 94 0.7× 142 1.0× 18 1.3k

Countries citing papers authored by P. C. Vincent

Since Specialization
Citations

This map shows the geographic impact of P. C. Vincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. C. Vincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. C. Vincent more than expected).

Fields of papers citing papers by P. C. Vincent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. C. Vincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. C. Vincent. The network helps show where P. C. Vincent may publish in the future.

Co-authorship network of co-authors of P. C. Vincent

This figure shows the co-authorship network connecting the top 25 collaborators of P. C. Vincent. A scholar is included among the top collaborators of P. C. Vincent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. C. Vincent. P. C. Vincent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gibson, John, D. Joshua, G. A. R. Young, et al.. (1989). A RANDOMISED TRIAL OF EMPIRICAL ANTIBIOTIC THERAPY IN FEBRILE NEUTROPENIC PATIENTS WITH HEMATOLOGICAL DISORDERS: CEFTAZIDIME VERSUS AZLOCILLIN PLUS AMIKACIN. Australian and New Zealand Journal of Medicine. 19(5). 417–425. 13 indexed citations
2.
Morris, T. C. M., P. C. Vincent, G. A. R. Young, et al.. (1989). CFU-GM inhibitors in neutropenia. Clinical & Laboratory Haematology. 11(1). 31–45. 2 indexed citations
3.
Lew, M., Sukhchain Singh, Sally M. Pittman, et al.. (1989). Cytogenetic abnormalities in benign lymphoid hyperplasia: A dual‐parameter study using chromosome analysis and flow cytometry. International Journal of Cancer. 44(6). 959–964. 7 indexed citations
4.
Young, G. A. R., et al.. (1987). The CFU-C assay in patients with neutropenia and, in particular, drug associated neutropenia. Clinical & Laboratory Haematology. 9(3). 245–254. 4 indexed citations
5.
Brown, Ross, E. Yuen, K.A. Rickard, et al.. (1986). Plasma lactoferrin in patients with neutropenia. Annals of Hematology. 52(5). 289–295. 13 indexed citations
6.
Vincent, P. C.. (1984). In vitro evidence of drug action in aplastic anemia. Annals of Hematology. 49(1). 3–12. 13 indexed citations
7.
Morris, T. C. M., et al.. (1984). CFU-C inhibitors in aplastic anaemia. Annals of Hematology. 48(2). 61–74. 6 indexed citations
8.
Young, G. A. R., et al.. (1984). Steroid responsive cyclical neutropenia. Annals of Hematology. 48(3). 153–159. 2 indexed citations
9.
Young, G. A. R. & P. C. Vincent. (1981). Cimetidine agranulocytosis. The Medical Journal of Australia. 2(9). 453–453.
10.
Chan, Wing C., et al.. (1980). Myeloproliferative and Lymphoproliferative Disorders in the Same Patient. Australian and New Zealand Journal of Medicine. 10(6). 650–653. 1 indexed citations
11.
Vincent, P. C.. (1979). Annual Review of Medicine: Selected Topics in the Clinical Sciences. Pathology. 11(2). 335–335. 2 indexed citations
12.
Morris, T. C. M., et al.. (1978). Letters to the Editor. Australian and New Zealand Journal of Medicine. 8(5). 550–553. 1 indexed citations
13.
Sutherland, R., et al.. (1977). Quinine-induced agranulocytosis: toxic effect of quinine bisulphate on bone marrow cultures in vitro.. BMJ. 1(6061). 605–607. 19 indexed citations
14.
Vincent, P. C., et al.. (1976). Tobramycin and Cephalothin Sodium in Treatment of Infected Patients with Acute Leukemia. The Journal of Infectious Diseases. 134(Supplement 1). S170–S174. 2 indexed citations
15.
Ford, J. H., et al.. (1975). Cytogenetic Basis of Acute Myeloid Leukemia. JNCI Journal of the National Cancer Institute. 55(4). 761–765. 25 indexed citations
16.
Levi, John A., et al.. (1973). Amodiaquine-induced Agranulocytosis: Toxic Effect of Amodiaquine in Bone Marrow Cultures In Vitro. BMJ. 1(5851). 458–460. 62 indexed citations
17.
Gunz, F. W., et al.. (1970). THE USE OF ETIOCHOLANOLONE FOR THE MEASUREMENT OF MARROW GRANULOCYTE RESERVES. The Medical Journal of Australia. 1(15). 763–767. 4 indexed citations
18.
Reeve, T. S., et al.. (1968). Blood Volume in Malignant Disease: Case Studies in 86 Females1. Australian and New Zealand Journal of Surgery. 38(2). 158–168. 1 indexed citations
19.
Lewis, S. M. & P. C. Vincent. (1968). Red‐Cell Density in Paroxysmal Nocturnal Haemoglobinuria. British Journal of Haematology. 14(5). 513–524. 8 indexed citations
20.
Vincent, P. C., et al.. (1967). THE EFFECT OF PIPENZOLATE ON GASTRIC SECRETION IN MAN. The Medical Journal of Australia. 1(11). 546–548. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026